CAMBRIDGE, Mass., June 05, 2023 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, will present and host in-person 1×1 investor meetings at the Goldman Sachs 44th Annual Global Healthcare Conference.
Goldman Sachs 44th Annual Global Healthcare Conference
Fireside Chat: Monday, June 12, 2023 at 8:00am PT
Location: Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA
A live webcast and archived replay of the fireside chat will be available on the investors section of our website, linked here: https://ir.vorbio.com/events-presentations/
About Vor Bio
Vor Bio is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit: www.vorbio.com.
Contact:
Media & Investors
Sarah Spencer
+1 857-242-6076
sspencer@vorbio.com
CHICAGO, IL / ACCESSWIRE / April 4, 2024 / The American College of Osteopathic Family…
WINNIPEG, MB / ACCESSWIRE / April 4, 2024 / Medicure Inc. ("Medicure" or the "Company")…
All resolutions presented by the Company have been adoptedPARIS, FRANCE AND CAMBRIDGE, MA / ACCESSWIRE…
LONDON, UK / ACCESSWIRE / April 4, 2024 / The UK is ‘in the grip…
Intuitive Health Opens 31st Location, Fourth with Presbyterian Healthcare ServicesPLANO, TX / ACCESSWIRE / April…
BELLEVUE, WAS / ACCESSWIRE / April 4, 2024 / Overlake Medical Center & Clinics has…